The interaction of bovine factor VIII with human platelets.
Treatment of human platelets with purified bovine Factor VIII caused three types of aggregation: (a) primary agglutination; (b) secondary aggregation involving the platelet release reaction; and (c) super-aggregation, in which the platelets were gathered into only a few large clumps. Removal of calcium ions or treatment with p-hydroxymercuiriphenyl sulfonate blocked the release reaction, but not primary agglutination or super-aggregation. Platelets treated with formalin were not aggregated by ADP, thrombin, or collagen, but were agglutinated by bovine Factor VIII, although they did not show super-aggregation. For malin-treated platelets were agglutinated by phytohemagglutinin P less extensively and less rapidly than by bovine Factor VIII. Treatment of platelets and Factor VIII with neuraminidase released 60 and 53%, respectively, of the sialic acid residues without affecting the agglutination reaction or the procoagulant activity of the Factor VIII. Agglutination was inhibited by high salt concentrations, dextran sulfate, and heparin. During agglutination, both the procoagulant and platelet-agglutinating activities of Factor VIII became bound to the platelet surface.
D000255:Adenosine Triphosphate / Q000032:analysis; D000371:Agglutination / Q000187:drug effects*; D000818:Animals; D002417:Cattle; D004492:Edetic Acid / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D005169:Factor VIII / Q000494:pharmacology*; D005557:Formaldehyde / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D006902:Hydroxymercuribenzoates / Q000494:pharmacology; D066298:In Vitro Techniques; D037102:Lectins / Q000494:pharmacology; D009439:Neuraminidase / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D011107:Polylysine / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D012794:Sialic Acids / Q000032:analysis; D012965:Sodium Chloride / Q000494:pharmacology; D013431:Sulfates / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology
D006902:Hydroxymercuribenzoates; D037102:Lectins; D012794:Sialic Acids; D013431:Sulfates; D005557:Formaldehyde; D011107:Polylysine; D012965:Sodium Chloride; D000255:Adenosine Triphosphate; D005169:Factor VIII; D006493:Heparin; D004492:Edetic Acid; D009439:Neuraminidase; D013917:Thrombin; D005033:Ethylmaleimide